Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - GILEAD SCIENCES INC | d260880d8k.htm |
| EX-99.2 - UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS - GILEAD SCIENCES INC | d260880dex992.htm |
| EX-99.3 - CONSENT OF GRANT THORNTON LLP - GILEAD SCIENCES INC | d260880dex993.htm |
| EX-99.1 - FINANCIAL STATEMENTS OF PHARMASSET, INC - GILEAD SCIENCES INC | d260880dex991.htm |
Exhibit 12.1
Gilead Sciences, Inc.
Computation of Ratio of Earnings to Fixed Charges
| Nine Months |
Year Ended December 31, | |||||||||||||||||||||||
| 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
| Earnings: |
||||||||||||||||||||||||
| Income before provision for income tax |
$ | 2,832,161 | $ | 3,913,548 | $ | 3,501,956 | $ | 2,672,698 | $ | 2,211,149 | $ | (677,275 | ) | |||||||||||
| Interest expense |
$ | 130,420 | $ | 108,961 | $ | 69,662 | $ | 65,244 | $ | 63,181 | $ | 53,164 | ||||||||||||
| Interest portion of operating lease expense |
$ | 12,073 | $ | 16,680 | $ | 14,920 | $ | 11,720 | $ | 11,520 | $ | 9,760 | ||||||||||||
| Net loss attributable to non-controlling interest |
$ | 11,192 | $ | 11,508 | $ | 10,163 | $ | 8,564 | $ | 9,108 | $ | 6,266 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total Earnings |
$ | 2,985,846 | $ | 4,050,697 | $ | 3,596,701 | $ | 2,758,226 | $ | 2,294,958 | $ | (608,085 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Fixed Charges: |
||||||||||||||||||||||||
| Interest expense |
$ | 130,420 | $ | 108,961 | $ | 69,662 | $ | 65,244 | $ | 63,181 | $ | 53,164 | ||||||||||||
| Capitalized Interest |
$ | 2,472 | $ | 1,473 | $ | 775 | $ | 120 | $ | 366 | $ | 517 | ||||||||||||
| Interest portion of operating lease expense |
$ | 12,073 | $ | 16,680 | $ | 14,920 | $ | 11,720 | $ | 11,520 | $ | 9,760 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total Fixed Charges |
$ | 144,965 | $ | 127,114 | $ | 85,357 | $ | 77,084 | $ | 75,067 | $ | 63,441 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Ratio of earnings to fixed charges |
20.6 | 31.9 | 42.1 | 35.8 | 30.6 | * | ||||||||||||||||||
| * | For the year ended December 31, 2006, our earnings were insufficient to cover fixed charges by $671.5 million. |